Follow
Jason Wiggins
Jason Wiggins
Mirna Therapeutics
Verified email at mirnarx.com
Title
Cited by
Cited by
Year
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
C Liu, K Kelnar, B Liu, X Chen, T Calhoun-Davis, H Li, L Patrawala, H Yan, ...
Nature medicine 17 (2), 211-215, 2011
16222011
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34
JF Wiggins, L Ruffino, K Kelnar, M Omotola, L Patrawala, D Brown, ...
Cancer research 70 (14), 5923-5930, 2010
8082010
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
P Trang, JF Wiggins, CL Daige, C Cho, M Omotola, D Brown, ...
Molecular Therapy 19 (6), 1116-1122, 2011
8012011
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
A Esquela-Kerscher, P Trang, JF Wiggins, L Patrawala, A Cheng, L Ford, ...
Cell cycle 7 (6), 759-764, 2008
7832008
Regression of murine lung tumors by the let-7 microRNA
P Trang, PP Medina, JF Wiggins, L Ruffino, K Kelnar, M Omotola, ...
Oncogene 29 (11), 1580-1587, 2010
6212010
Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice
AM Firoved, GF Miller, M Moayeri, R Kakkar, Y Shen, JF Wiggins, ...
The American journal of pathology 167 (5), 1309-1320, 2005
2122005
Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer
CL Daige, JF Wiggins, L Priddy, T Nelligan-Davis, J Zhao, D Brown
Molecular cancer therapeutics 13 (10), 2352-2360, 2014
1792014
Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity
M Moayeri, NW Martinez, J Wiggins, HA Young, SH Leppla
Infection and immunity 72 (8), 4439-4447, 2004
1142004
Anthrax protective antigen cleavage and clearance from the blood of mice and rats
M Moayeri, JF Wiggins, SH Leppla
Infection and immunity 75 (11), 5175-5184, 2007
882007
Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse development
S Liu, JF Wiggins, T Sreenath, AB Kulkarni, JM Ward, SH Leppla
Molecular and cellular biology 26 (10), 3835-3841, 2006
752006
Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice
Y Gozes, M Moayeri, JF Wiggins, SH Leppla
Infection and immunity 74 (2), 1266-1272, 2006
622006
Cisplatin inhibition of anthrax lethal toxin
M Moayeri, JF Wiggins, RE Lindeman, SH Leppla
Antimicrobial agents and chemotherapy 50 (8), 2658-2665, 2006
502006
Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin
M Moayeri, JI Webster, JF Wiggins, SH Leppla, EM Sternberg
Infection and immunity 73 (7), 4238-4244, 2005
412005
Anthrax edema toxin sensitizes DBA/2J mice to lethal toxin
AM Firoved, M Moayeri, JF Wiggins, Y Shen, WJ Tang, SH Leppla
Infection and immunity 75 (5), 2120-2125, 2007
352007
Oxidized ATP protection against anthrax lethal toxin
M Moayeri, KE Wickliffe, JF Wiggins, SH Leppla
Infection and immunity 74 (7), 3707-3714, 2006
292006
The system can't perform the operation now. Try again later.
Articles 1–15